Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Total Non-Current Liabilities (2023 - 2025)

Camp4 Therapeutics' Total Non-Current Liabilities history spans 3 years, with the latest figure at -$47.7 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 414.8% year-over-year to -$47.7 million; the TTM value through Dec 2025 reached -$47.7 million, down 414.8%, while the annual FY2025 figure was -$47.7 million, 414.8% down from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was -$47.7 million at Camp4 Therapeutics, down from $11.0 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $18.2 million in Q3 2024 and bottomed at -$51.6 million in Q1 2025.
  • The 3-year median for Total Non-Current Liabilities is $11.0 million (2025), against an average of -$11.2 million.
  • The largest annual shift saw Total Non-Current Liabilities dropped 8.25% in 2024 before it crashed 414.8% in 2025.
  • A 3-year view of Total Non-Current Liabilities shows it stood at $16.5 million in 2023, then decreased by 8.25% to $15.2 million in 2024, then plummeted by 414.8% to -$47.7 million in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Total Non-Current Liabilities are -$47.7 million (Q4 2025), $11.0 million (Q3 2025), and -$40.0 million (Q2 2025).